Cell surface heparan sulfate proteoglycans as novel markers of human neural stem cell fate determination  by Oikari, Lotta E. et al.
Stem Cell Research 16 (2016) 92–104
Contents lists available at ScienceDirect
Stem Cell Research
j ourna l homepage: www.e lsev ie r .com/ locate /scrCell surface heparan sulfate proteoglycans as novel markers of human
neural stem cell fate determinationLotta E. Oikari, Rachel K. Okolicsanyi, Aro Qin, Chieh Yu, Lyn R. Grifﬁths, Larisa M. Haupt ⁎
Genomics Research Centre, Institute of Health and Biomedical Innovation, Queensland University of Technology, Musk Avenue, Kelvin Grove, Brisbane, Queensland 4059, Australia⁎ Corresponding author at: Institute of Health and Biom
University of Technology, 60 Musk Ave, Kelvin Grove, QLD
E-mail address: larisa.haupt@qut.edu.au (L.M. Haupt).
http://dx.doi.org/10.1016/j.scr.2015.12.011
1873-5061/© 2015 The Authors. Published by Elsevier B.Va b s t r a c ta r t i c l e i n f oArticle history:
Received 9 July 2015
Received in revised form 13 November 2015
Accepted 15 December 2015
Available online 17 December 2015Multipotent neural stem cells (NSCs) provide a model to investigate neurogenesis and develop mechanisms of
cell transplantation. In order to deﬁne improved markers of stemness and lineage speciﬁcity, we examined
self-renewal andmulti-lineagemarkers during long-term expansion and under neuronal and astrocyte differen-
tiating conditions in human ESC-derived NSCs (hNSC H9 cells). In addition, with proteoglycans ubiquitous to the
neural niche,we also examinedheparan sulfate proteoglycans (HSPGs) and their regulatory enzymes. Our results
demonstrate that hNSCH9 cellsmaintain self-renewal andmultipotent capacity during extended culture and ex-
press HS biosynthesis enzymes and several HSPG core protein syndecans (SDCs) and glypicans (GPCs) at a high
level. In addition, hNSC H9 cells exhibit high neuronal and a restricted glial differentiative potential with lineage
differentiation signiﬁcantly increasing expression of many HS biosynthesis enzymes. Furthermore, neuronal dif-
ferentiation of the cells upregulated SDC4, GPC1, GPC2, GPC3 and GPC6 expression with increased GPC4 expres-
sion observed under astrocyte culture conditions. Finally, downregulation of selected HSPG core proteins altered
hNSC H9 cell lineage potential. These ﬁndings demonstrate an involvement for HSPGs in mediating hNSC main-
tenance and lineage commitment and their potential use as novel markers of hNSC and neural cell lineage
speciﬁcation.







Neural stem cells (NSCs) are retained in the adult brain in discrete
locations and maintain the ability to self-renew and differentiate into
neural cell lineages — neurons, astrocytes and oligodendrocytes (Gage,
2000). Isolated NSCs not only can be propagated in vitro in the presence
of ﬁbroblast growth factor 2 (FGF-2) and epidermal growth factor (EGF)
as free-ﬂoating neurospheres (Reynolds and Weiss, 1992) but also can
be derived from embryonic stem cells (ESCs), which can be expanded
as an adherent monolayer circumventing the challenges associated
with long-term neurosphere culture (Conti et al., 2005, Zhang et al.,
2001). NSCs provide a model of nervous system development and
they have great therapeutic potential for the treatment of CNS injuries
and disease. A better understanding of factors regulating their behav-
iour is required to fully exploit the capacity of these cells.
NSCswith self-renewal andmultipotentiality express the intermedi-
ate ﬁlament nestin, transcription factors SOX1 and SOX2 and the RNA-
binding protein Musashi 1 (MSI1), all shown to play a role in NSC self-
renewal and thus in the maintenance of the NSC pool (Christie et al.,
2013, Okano et al., 2005). In addition, the expression of telomeraseedical Innovation, Queensland
4059, Australia.
. This is an open access article under(TERT) is considered a marker of true stem cell self-renewal
(Thomson et al., 1998). Neuronal differentiation is indicated by in-
creased expression of neuron-speciﬁc markers including βIII-tubulin
(TUBB3), microtubule-associated protein 2 (MAP2), neuroﬁlaments
(NEFs) and doublecortin (DCX) (Brown et al., 2003, Laser-Azogui
et al., 2015, Song et al., 2002).Markers denoting the astrocyte lineage in-
clude glial ﬁbrillary acidic protein (GFAP), surface marker CD44 and
S100B calcium binding protein (Donato, 2001, Reeves et al., 1989,
Sosunov et al., 2014) and ﬁnally, oligodendrocyte lineage markers in-
clude galactosylceramidase (GalC), transcription factors Olig1 and
Olig2 and surface markers O1 and O4 (Barateiro and Fernandes, 2014,
Tracy et al., 2011).
However, there is an overlap in expression of these markers be-
tween lineages. For example nestin, MSI1 and MAP2, expressed by im-
mature NSCs and neuronal cells are also expressed by reactive
astrocytes (Duggal et al., 1997, Geisert et al., 1990, Oki et al., 2010)
and Olig1 and Olig2 expressed by motor neurons with Olig2 also
shown to be required for NSC proliferation and maintenance (Ligon
et al., 2007, Zhou and Anderson, 2002). Thus, the identiﬁcation of new
lineage speciﬁcation markers and/or deﬁning novel combinations of
markers would enable the more efﬁcient utilisation of lineage-speciﬁc
neural cells.
The NSC microenvironment, or niche, plays a central role in regulat-
ing NSC stemness (self-renewal and differentiation) with localthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lineage differentiation (Ramasamy et al., 2013). The distribution and ac-
tivity of extracellular signallingmolecules aremediated by extracellular
matrix (ECM) components, including proteoglycans (PGs). PGs consist
of a core protein and attached sulfated glycosaminoglycan (GAG) chains
that determine their classiﬁcation and inﬂuence local concentrations of
growth factors and ligands (Couchman and Pataki, 2012, Dreyfuss et al.,
2009). The heparan sulfate proteoglycans (HSPGs) consist of twomajor
families: the type I transmembrane syndecans (SDC1-4), and the globu-
lar GPI-anchored glypicans (GPC1-6) (Choi et al., 2011, Filmus et al.,
2008).
HS chains are synthesised post-translationally via a complex tempo-
ral process mediated by a number of biosynthesis enzymes to assemble
chains to the core proteins. HS chains are ﬁrst polymerised by exostosin
glycosyltransferases 1 and 2 (EXT1 and EXT2) (Busse et al., 2007),
followed by modiﬁcations catalysed by N-deacetylase/N-
sulfotransferases (NDSTs; NDST1-4) and epimerisation catalysed by
C5-epimerase (C5-EP) (Grobe et al., 2002). Finally, the HS chains are
sulfated byHS 2-O-sulfotransferase (HS2ST1) and 6-O-sulfotransferases
(HS6ST1, HS6ST2 and HS6ST3), respectively (Esko and Selleck, 2002).
HS chain length alongwith theN- and O-sulfation pattern subsequently
determines the binding abilities of HSPGs (Esko and Selleck, 2002).
SDCs and GPCs have been reported to regulate cell adhesion, migra-
tion and differentiation and demonstrate speciﬁc expression and
localisation during CNS development (Choi et al., 2011, Ford-Perriss
et al., 2003). The depletion of SDC1, GPC1 and GPC4 in vitro in mouse
NSC or neural precursor cells alters cell maintenance and proliferation
(Abaskharoun et al., 2010, Fico et al., 2012, Wang et al., 2012) and the
depletion of EXT1, NDST1, HS2ST1 or HS6ST1 in the mouse CNS results
in brain malformations and abnormalities (Grobe et al., 2005, Inatani
et al., 2003, Pratt et al., 2006). Currently the role of HSPGs in human
NSC (hNSC) lineage speciﬁcation is limited and reliant upon rodent
models: despite the acknowledged differences in development, struc-
ture and regulation between human and rodent nervous systems
(reviewed in Oikari et al., 2014). To elucidate key HSPGs in hNSC regu-
lation we expanded hESC-derived NSCs (hNSC H9 cells) and examined
the expression of NSC self-renewal and neural cell lineage markers
along with HS biosynthesis enzymes and SDC and GPC core proteins
in basal and lineage speciﬁc differentiation (neuronal and glial) cul-
tures. Our results identify HSPGs as potential regulators of hNSC lineage
potential and support their use as additional markers of neural cell
speciﬁcation.
2. Materials and methods
2.1. hNSC H9 cell expansion
Two populations of human neural stem cells derived from the NIH
approved H9 (WA09) human embryonic stem cells (hNSC H9 cells)
were purchased from Life Technologies and expanded until passage 31
(P31) corresponding to approximately 100 days in culture. Basal culture
conditions included expanding cells as a monolayer on Geltrex® coated
culture vessels in neural stem cell serum-free medium (NSC SFM)
containing Knockout™ DMEM/F-12, 2% StemPro® Neural Supplement,
20 ng/mL of FGF-2 and EGF, and 2 mM GlutaMAX™-I all obtained from
GIBCO®, Life Technologies. Cells were maintained at 37 °C in 5% CO2 in
a humidiﬁed atmosphere and passaged every 3–5 days using TrypLE
(Life Technologies) and re-plated at a density of 5 × 104 cells/cm2. The
viability of the cellswasmonitoredusing TrypanBlue and an automated
cell counter (Bio-Rad) and via hemacytometer.
2.2. hNSC H9 neuron and astrocyte differentiation cultures
hNSC H9 cells were cultured under lineage-speciﬁc differentiation
conditions according to protocols provided by Life Technologies. For
neuronal lineage differentiation, hNSC H9 cells were plated on poly-L-ornithine-laminin coated culture vessels at a seeding density of
2.5 × 104 cells/cm2; for astrocyte lineage differentiation, hNSC H9 cells
were plated on Geltrex® coated culture vessels at a seeding density of
2 × 104 cells/cm2. Cells were allowed to attach in NSC SFM for two
days. Neuronal differentiation was induced by maintaining cells in
Neurobasal® Medium (Life Technologies) supplemented with 2% B-
27® Serum-Free Supplement and 2 mM GlutaMAX™-I (Life Technolo-
gies) with the astrocyte differentiation conditions consisting of DMEM
supplemented with 1% N-2 supplement (Life Technologies), 2 mM
GlutaMAX™-I and 1% FBS. Cells were maintained in differentiating con-
ditions for 15 to 18 days with the medium changed every 3–4 days.
2.3. RNA-interference
hNSC H9 P5 cells were plated in NSC SFM at a density of 5 ×
104 cells/cm2 and allowed to attach for 48 h prior to treatment
with Accell™ Smartpool Human siRNAs (Dharmacon), a pool of
four siRNA transcripts speciﬁc to GPC1 (E-004303-00-0010) or
GPC4 (E-011271-00-0010). For siRNA delivery, the growth medi-
um was changed to Accell™ siRNA Delivery Media containing
1 μM of siRNA supplemented with 2% StemPro® Neural Supple-
ment and 20 ng/mL of FGF-2 and EGF. Untreated and non-
targeting (scramble) siRNA (D-001,910-10-20) treated cells were
used as a control. Cells were incubated with siRNAs for 72 h
after which cell number and viability were assessed and cells har-
vested for RNA extraction.
2.4. Total RNA extraction, cDNA synthesis and Q-PCR
RNA was harvested using TRIzol® reagent (Invitrogen) with the
Direct-zol™ RNA miniprep kit (Zymo Research) according to the
manufacturer's instructions. During extraction samples were treated
in-column with DNase I (Zymo Research) for 15 min to eliminate DNA
contamination. cDNA synthesis was performed using Roche
Transcriptor Reverse Transcriptase. Brieﬂy, 150 ng of RNA was incubat-
ed with 3 μg of Random Primer (Invitrogen) at 65 °C for 10 min in a re-
action volume of 19.5 μl. Samples were then incubated with 10 U of RT
enzyme in 1× RT reaction buffer, with 1 mM dNTPs (New England
Biolabs), 20 U of RNaseOUT (Invitrogen) in a total reaction volume of
30 μl for 10 min at 25 °C, followed by 30 min at 55 °C and a ﬁnal step
of 5 min at 85 °C.
Q-PCR reactions were performed in quadruplicate per sample for
each gene studied in a 384-well microtiter plate. Each reaction
contained 120 ng of cDNA template, 5 μl of SYBR®-Green PCR Master
Mix (Promega), 200 ng of forward and reverse primer and 0.1 μl of
CXR reference dye (Promega). Ampliﬁcation was monitored using a
Life Technologies QuantStudio™-7 with an enzyme activation of 2 min
at 50 °C and 3 min at 95 °C followed by 50 cycles of 15 s at 95 °C and
1 min at 60 °C. Cycle threshold (Ct) values were normalised against
the endogenous control gene 18S Ct values (ΔCt) included in each
run. Relative gene expression was determined by calculating the ΔΔCt
value (2(−ΔCt)) and relative expression values presented on bar graphs
are ΔΔCt × 106. All primer sequences for the genes studied can be found
in Tables 1 and 2 in Oikari et al. (2015).
2.5. Immunoﬂuorescence
For immunoﬂuorescent (IF) detection of target proteins, cells in
basal growth conditions were plated on CC2-coated chamber slides
(Lab-Tek) at 5 × 104 cells/chamber and allowed to attach for 2 days. Dif-
ferentiating cells were plated in 48-well culture dishes (Corning) and
stained between D14 and D18. Prior to staining, cells were washed
with 1× PBS with Ca2+ andMg2+ and ﬁxed with 4% paraformaldehyde
then blocked with 1% BSA and 5% donkey serum in 1× PBS with Ca2+
and Mg2+. For intracellular proteins 0.1% of Triton-X was included in
the blocking solution to allow permeabilisation. After blocking, primary
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cubated overnight at 4 °C. The following primary antibodies and dilu-
tions were used: anti-Nestin (ab22035, Abcam, 1:200), anti-SOX2
(AB5603, Millipore, 1:1000), anti-TUBB3 (ab18207, Abcam, 1:1000),
anti-S100B (ab868, Abcam, 1:200), anti-O1 (MAB344, Millipore,
1:500), anti-syndecan 4 (ab24511, Abcam, 1:1000), anti-glypican 1
(ab137604, Abcam, 1:1000), anti-glypican 4 (ab100843, Abcam,
1:500) and 10E4 HS antibody (370255-S, amsbio 1:500). After over-
night incubation cells were washed with 1× PBS with Ca2+ and Mg2+
secondary antibodies applied and cells incubated at room temperature
for 2 h. Finally, cells were rinsed with 1× PBS with Ca2+ and Mg2+,
and counterstained with ﬂuoroshield mounting medium with DAPI
(ab104139, Abcam). Images were taken on an Olympus IX81 inverted
phase-contrast ﬂuorescent microscope using Volocity software (Perkin
Elmer) on a Hamamatsu Orca camera. Isotype controls and secondary
antibodies used can be found in Table 3 in Oikari et al. (2015).
2.6. Western blotting
Total protein was extracted using protein-lysis buffer (20 mM
HEPES, 25% glycerol, 1.5 mM MgCl2, 420 mM NaCl, 0.5 mM DTT,
0.2 mM EDTA, 0.5% Igepal CA-630, 0.2 mM Na3VO4, 1 mM PMSF and
dH2O containing protease and phosphatase inhibitors). Protein concen-
tration was determined using the BCA protein quantitation assay
(Pierce) with ~50 μg of total protein separated by SDS-PAGE using
12% pre-cast gels (Mini-PROTEAN®TGX™, Bio-Rad). For the detection
of HSPG core proteins using the monoclonal antibody HS Δ3G10, pro-
tein samples were treated with 1.5 mU Heparitinase (Seikagaku
Biobusiness) for 2.5 h at 37 °C before separation. After separation, pro-
tein was transferred to a PVDF membrane, the membrane blocked
with 5% milk and primary antibodies diluted in 5% BSA incubated on
the membrane overnight. Primary antibodies used were: anti-SOX2
(#AB5603, Millipore), anti-TUBB3 (ab18207, Abcam), anti-CD44
(ab6124, Abcam), anti-Δ3G10 (H1890-75, US Biological) and anti-
GAPDH (#2118, Cell Signaling) as loading control. The membrane was
then washed with TBST and incubated with HRP-conjugated secondary
antibodies (anti-Rabbit IgG, #7074 and anti-Mouse IgG, #7076, both
from Cell Signaling) diluted in 5% BSA for 2 h at room temperature.
Detection of target proteins was performed with ECL (Clarity™ ECL,
Bio-Rad) using the Fusion FX Spectra chemiluminescence system
(Vilber Lourmat, Fisher Biotec) with optical quantitation performed
using Bio-1D software.
2.7. Statistical analysis
Expansion, differentiation and RNA-interference (RNAi) experi-
ments consisted of two biological replicates (hNSC H9 POP1 and
POP2) with RNA and protein samples of differentiated and RNAi cul-
tures consisting of 2–4 pooledwells. For IF images the average signal in-
tensity was calculated by normalising the mean signal intensity to
exposure time and dividing it by the number of nuclei. The signal inten-
sities and nuclei count were obtained using Volocity software and
values presented are an average between 2 and 4 images. Statistical sig-
niﬁcance was determined using a paired t-test and deﬁned as * p b 0.5,
** p b 0.01 and *** p b 0.001.
3. Results
3.1. hNSC H9 expansion and lineage characterisation
Commercially available hNSC H9 cells (POP1 and POP2) were inde-
pendently established and expanded as a monolayer on Geltrex® until
passage 31 (P31) corresponding to approximately 100 days in culture
(Fig. 1A). Cells were passaged at 90–100% conﬂuence approximately
every 3–4 days and re-plated at a seeding density of 5 × 104 cells/cm2.Cell number and viability were assessed using Trypan Blue on an auto-
mated cell counter as well as via hemacytometer with morphology of
the cells monitored under a phase contrast microscope and images
taken at each passage at D1. For gene expression analysis, RNAwas har-
vested fromboth populations at passages 2, 5, 7, 11, 13, 17, 21, 23, 27/28
and 31 and gene expression results presented as the average for both
populations at passages P2–P5, P7–P11, P13–P17, P21–23 and P27–P31.
Cells exhibited linear growth and a high level of homogeneity
throughout expansion (Fig. 1A–B). A similar growth rate was observed
for both populations until P6, after which POP2 grew faster with P31
reached at D87 with POP1 reaching P31 after 105 days in culture
(Fig. 1A). The averaged viability for both populations remained between
60 and 84% with decreased viability observed between P2 (84%) and
P31 (60%) (Fig. 1A). Cells acquired minimal morphological changes be-
tween P2, P5, P17 and P31 (corresponding to averaged 2, 12, 52 and
96 days in culture) (Fig. 1B) and maintained human TERT (hTERT) ex-
pression, with no signiﬁcant change observed in expression between
P27–P31 and P2–P5 (Fig. 1C).
Expanded hNSC H9 cultures were examined for expression of NSC
self-renewal as well as neural speciﬁc lineage markers at passages P2–
P5, P7–P11, P13–P17, P21–P23 and P27–P31. NSC markers nestin,
SOX1, SOX2 and MSI1 gene expression were observed throughout ex-
pansion (Fig. 2A). SOX2 was expressed at the highest level and its ex-
pression signiﬁcantly upregulated (p = 0.008) in P27–P31 cultures
when compared to P2–P5. Neuronal markers TUBB3, MAP2, medium
molecular weight NEF (NEFM) and DCX were expressed during expan-
sion with TUBB3 demonstrating the highest expression level, followed
by MAP2, NEFM and DCX, respectively (Fig. 2B). TUBB3 (p = 0.002)
and MAP2 (p = 0.02) were signiﬁcantly upregulated at late passages
(P27–P31) when compared to early passage (P2–P5) cells.
hNSC H9 cells also expressed glial markers, denoting astrocyte
(S100B and CD44) and oligodendrocyte (GalC, Olig1 and Olig2) lineages
(Fig. 2C–D). The observed expression levels of glial markers remained
markedly lower than neuronal markers with the neuronal marker
TUBB3 (N50 × 106) expressed approximately at a 50 times higher
level than the glial markers (~1 × 106) at P2–P5. Signiﬁcant upregula-
tion of the astrocyte marker S100B (p = 0.0008) and oligodendrocyte
markers Olig1 (p = 0.04) and Olig2 (p = 0.007) in late passages
(P27–P31) was observed (Fig. 2C–D) with GFAP expression absent or
only intermittently present in a few passages (data not shown).
We then examined the cultures for expression of a panel of NSC and
neural cell lineage markers via IF. NSC markers nestin and SOX2 as well
as neuronal (TUBB3), astrocyte (S100B) and oligodendrocyte (O1)
markers were observed at early (P5), mid (P17) and late (P31) passages
(Fig. 2E). Nestin, SOX2 and TUBB3 demonstrated a homogeneous expres-
sion pattern with S100B showing high expression only in a few cells and
the average signal intensity for O1 was the lowest when compared to
other markers studied (Fig. 2F). Increased SOX2 expression was demon-
strated via Western analysis indicative of self-renewal during extended
culture (Fig. 2G). The combined expression proﬁle of neuronal, astrocyte
and oligodendrocyte lineage markers examined demonstrate hNSC H9
cells maintain multipotentiality during extended in vitro expansion.3.2. HSPGs during hNSC H9 expansion
Following conﬁrmation of maintenance of self-renewal and expres-
sion of multi-lineage markers during long-term expansion we then
studied the expression of HS regulatory enzymes and SDCs and GPCs
in hNSC H9 cells from early (P2–P5) to late stages (P27–P31) of expan-
sion. HS biosynthesis genes were expressed in hNSC H9 cells including
elongation (EXT1 and EXT2), modiﬁcation (NDST1–4 and C5-EP) and
sulfation (H2ST1, HS6ST1–3) enzymes with clear differences in expres-
sion levels observed between several of the enzymes (Fig. 3A–D). This
included higher relative expression of EXT1 than EXT2 with EXT1 ex-
pression signiﬁcantly downregulated (p=0.02) in late passage cultures
Fig. 1. Expansion of hNSC H9 cells. A) Growth curve of hNSC H9 populations (POP1 and POP2) expanded to passage 31 (P31). Cells exhibit a linear growth pattern and maintain 60–80%
viability. B) Phase contrast images (20× magniﬁcation, scale bar 130 μM) of hNSC H9 cells at P2, P5, P17 and P31 corresponding to an average of 2 days, 12 days, 52 days and 96 days in
culture. C) Relative expression of hTERT in hNSC H9 cells at passages 2–5, 7–11 13–17, 21–23 and 27–31 (error bars = SEM).
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followed by NDST2 with NDST3 and NDST4 expressed at a low level
(Fig. 3B). Of the sulfotransferases HS2ST1 was most highly expressed,
followed by HS6ST1, HS6ST2 and HS6ST3, respectively (Fig. 3D). In ad-
dition, HS2ST1 expression was signiﬁcantly downregulated (p = 0.01)
and HS6ST2 signiﬁcantly upregulated (p = 0.03) in late passage
cultures.
HSPG core protein SDC2 demonstrated the highest expression level
followed by SDC3, SDC1 and SDC4, respectively (Fig. 3E) in hNSC cul-
tures. Both SDC2 (p=0.03) and SDC3 (p=0.02) signiﬁcantly increased
expression at late passages (P27-P31)when compared to early passages
(P2–P5) (Fig. 3E). GPC1, GPC2, GPC3, GPC4 and GPC6were expressed in
hNSC H9 cultures, but no GPC5 expression was detected (Fig. 3F). GPC4
was most abundantly expressed followed by GPC1, GPC2, GPC3 and
GPC6, respectively (Fig. 3F). The expression of GPC2 (p = 0.0003) and
GPC4 (p = 4.3e-5) was highly signiﬁcantly increased in later passage
(P27–P31) cultures. Detection of the HS 10E4-epitope via IF demon-
strated localised HS providing further conﬁrmation that hNSC H9 cells
maintain HS expression throughout expansion (P5 to P31) (Fig. 3G).3.3. Markers of hNSC H9 neuronal and astrocyte lineage differentiation
In order to conﬁrm hNSC multipotency and to identify any associat-
ed changes in the HSPG proﬁle following lineage commitment, cells
were examined during neuronal and astrocyte differentiating condi-
tions. Due to low differentiation efﬁciency and poor viability of the
cells following initiation of oligodendrocyte differentiation, this lineage
was not further examined. Neuronal and astrocyte differentiation was
induced for 14–18 days in both populations in P5 cells and during differ-
entiation; cells were monitored for morphological changes as well as
expression changes in lineage and HSPG genes.
Cells cultured in neuronal differentiating conditions acquired thin,
elongated protrusions, while astrocyte lineage cultures exhibited a
large cell body when compared to basal and neuronal cultures
(Fig. 4A). Gene expression levels of the NSC markers nestin, SOX1 and
SOX2 were not altered following differentiation while MSI1, also a
marker of reactive astrocytes, was highly signiﬁcantly upregulated in
astrocyte cultureswhen compared to basal (p=7.2e−6) and neuronal
(p = 0.0001) cultures (Fig. 4B). All neuronal markers examined were
Fig. 2.hNSCH9 cells express NSC self-renewal, neuronal, astrocyte and oligodendrocyte lineagemarkers throughout expansion. Averaged (POP1 and POP2) relative expression inhNSCH9
cultures of A) NSCmarkers nestin, SOX1, SOX2 andMSI1, B) neuronalmarkers TUBB3,MAP2, NEFMand DCX, C) astrocytemarkers S100B and CD44 and D) oligodendrocytemarkers GalC,
Olig1 and Olig2 at passages 2–5, 7–11 13–17, 21–23 and 27–31 (error bars= SEM, * p b 0.05, ** p b 0.01, *** p b 0.001). Immunoﬂuorescence of E) NSCmarkers nestin and SOX2, neuronal
marker TUBB3, astrocyte marker S100B and oligodendrocyte marker O1 in hNSC H9 cells at passages 5, 17 and 31, counterstained with DAPI (40× magniﬁcation, scale bar 130 μM).
F) Average signal intensity of IF (error bars = SD). G) Western blot analysis of SOX2 at passage P3–P5, P7–P11, P13–P17, P21–P23 and P27–P31 with GAPDH loading control.
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Fig. 3. hNSC H9 cells express HSPGs and HS biosynthesis enzymes. Averaged (POP1 and POP2) relative expression in hNSC H9 cultures of A) EXT1 and EXT2, B) N-deacetylase/N-
sulfotransferases (NDST1-4), C) C5-epimerase, D) 2-O/6-O sulfotransfereases, E) SDC 1–4 and F) GPC 1-4 and 6 at passages 2–5, 7–11, 13–17, 21–23 and 27–31 (error bars = SEM, *
p b 0.05, ** p b 0.01, *** p b 0.001). G) Immunoﬂuorescence of pan HS 10E4 epitope in hNSC H9 cells at P5, P17 and P31 counterstained with DAPI (40× magniﬁcation, scale bar 130 μM).
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Fig. 4.Neuronal and astrocyte differentiation of hNSCH9 cells alters cellmorphology andmarker expression. A)Neuronal and astrocyte lineage phase images of hNSCH9P5 cells (20× and
40×magniﬁcation, scale bar 130 μM). Averaged (POP1 and POP2) relative expression of B) NSC C) neuronal and D) astrocyte markers and E)Western analysis of TUBB3, SOX2 and CD44
(GAPDH loading control) following neuronal and astrocyte differentiation. F) Immunoﬂuorescence of nestin and SOX2, TUBB3 and S100B in hNSCH9, neuronal and astrocyte lineage cells
(20×magniﬁcation, scale bar 130 μM)with average signal intensity graph (G). (Error bar = SD for CD44 relative expression astrocyte condition and average signal intensity graph, other
error bars = SEM, * p b 0.05, ** p b 0.01, *** p b 0.001.)
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cultures including: TUBB3 (p = 0.03), MAP2 (p = 0.02), NEFM (p =
0.0006) and DCX (p = 0.02) (Fig. 4C). Furthermore, NEFM (p =0.002) and DCX (p = 0.03) were signiﬁcantly upregulated in neuronal
cultures when compared to astrocyte cultures (Fig. 4C). Interestingly,
TUBB3 (p = 0.009), MAP2 (p = 5.8e−8), NEFM (p = 0.01) and DCX
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pared to basal cultures, however, the expression level of NEFM and
DCX in astrocyte cultures remained lower than in neuronal cultures
(Fig. 4C). The astrocyte marker S100B was undetectable by Q-PCR in
neuronal cultures, while it was highly signiﬁcantly upregulated (p =
6e−5) in astrocyte cultures when compared to basal cultures
(Fig. 4D). In addition, the glialmarker CD44was signiﬁcantly upregulat-
ed in both neuronal (p = 0.008) and astrocyte (p = 0.0003) cultures
when compared to basal hNSC H9 cells, with higher relative expression
observed in neuronal cultured cells (Fig. 4D). Western analysis con-
ﬁrmed upregulation of TUBB3, SOX2 and CD44 in neuronal culturesFig. 5. HS biosynthesis enzymes and HSPG core protein (SDC and GPC) expression in hNSC H9
relative expression of A) exostoses EXT1 and EXT2 and C5-Epimerase, B) N-deacetylase/N-sulf
hNSC H9 neuronal and astrocyte differentiation (error bar for NDST3 basal hNSC H9 condition =
and optical quantitation of the HS Δ3G10 epitope in basal and lineage differentiated cells.when compared to both basal and astrocyte cultures (Fig. 4E). No pro-
tein level expression of the astrocyte marker S100B was observed
under any culture conditions.
IF demonstrated that the neuronal cultures exhibited signiﬁcantly
decreased average signal intensity of nestin (vs. hNSC H9 p = 0.04, vs.
astrocyte p = 0.005) and SOX2 (vs. hNSC H9 p = 0.048, vs. astrocyte
p = 0.029) compared to other culture conditions with astrocyte cul-
tures demonstrating increased nestin intensity compare to basal cul-
tures (p = 0.02) (Fig. 4F–G). Furthermore, although not signiﬁcant,
neuronal cultures demonstrated the highest TUBB3 signal intensity
compared to other conditions and a signiﬁcantly decreased signalcells following neuronal and astrocyte lineage differentiation. Averaged (POP1 and POP2)
otransferases and C) HS 2-O/6-O-sulfotransferases D) SDC1-4 and E) GPC1-4, 6 following
SD, other error bars= SEM, * p b 0.05, ** p b 0.01, *** p b 0.001). F–G)Western analysis
100 L.E. Oikari et al. / Stem Cell Research 16 (2016) 92–104intensity of S100B compared to basal (p = 0.008) and astrocyte (p =
0.03) cultures. The average signal intensity of S100B in astrocyte cul-
tures remained lower than in basal cultures (p= 0.008) (Fig. 4G), how-
ever, a high number of cells demonstrated strong S100B staining in
these cultures (Fig. 4F).
3.4. Lineage speciﬁc changes in HSPG expression
Multiple HS biosynthesis enzymes exhibited a signiﬁcant increase in
expression when examined by Q-PCR following neuronal and astrocyte
lineage differentiation. The HS polymerising enzyme EXT2 was highly
signiﬁcantly upregulated in neuronal cultures when compared to both
basal (p = 4.2e−5) and astrocyte (p = 0.0001) cultures and the HS
modifying enzyme C5-EPwas signiﬁcantly upregulated in neuronal cul-
tureswhen compared to astrocyte cultures (p=0.02) (Fig. 5A). Follow-
ing lineage commitment NDST2 was signiﬁcantly upregulated (p =
0.04) in neuronal cultures compared to basal and astrocyte cultures;
NDST3 was signiﬁcantly upregulated in both neuronal and astrocyte
(p = 0.003) cultures compared to basal cultures, with a signiﬁcant dif-
ference also observed between neuronal and astrocyte cultures (p =
0.04); and ﬁnally, NDST4was highly signiﬁcantly upregulated in neuro-
nal cultures when compared to basal (p= 4.1e−5) and astrocyte (p=
0.0006) cultures (Fig. 5B). The expression level of HS2ST1 was not al-
tered following hNSC H9 cell differentiation, however, HS6ST2 (p =
0.006) and HS6ST3 (p= 0.02) were signiﬁcantly upregulated in neuro-
nal cultures when compared to basal cultures with HS6ST2 also signiﬁ-
cantly upregulated (p = 0.03) in neuronal cultures when compared to
astrocyte cultures (Fig. 5C). Finally, HS6ST1 (p = 0.049) and HS6ST2
(p = 0.013) were signiﬁcantly upregulated following astrocyte lineage
differentiation when compared to basal hNSC H9 cultures (Fig. 5C).
Gene expression of SDC1, SDC2 and SDC3were not altered following
neuronal differentiation, interestingly, however, SDC4 expression was
signiﬁcantly upregulated (P = 0.03) in neuronal cultures when com-
pared to basal and astrocyte cultures (Fig. 5D). In addition, SDC2 was
signiﬁcantly upregulated (p = 0.011) in astrocyte cultures when com-
pared to neuronal cultures (Fig. 5D). Signiﬁcant increases in expression
were observed for several GPCs in neuronal cultures when compared to
basal and astrocyte cultures as follows: GPC1 neuronal vs. basal (p =
0.049), neuronal vs. astrocyte (p = 0.048); GPC2 neuronal vs. basal
(p = 0.009) and neuronal vs. astrocyte (p = 0.011); GPC3 neuronal
vs. basal (p = 0.014) and neuronal vs. astrocyte (p = 0.013); and
GPC6 neuronal vs. basal (p = 0.009) and neuronal vs. astrocyte (p =
0.02) (Fig. 5E). GPC4 was highly signiﬁcantly upregulated in astrocyte
differentiating cultures when compared to basal (p= 0.0001) and neu-
ronal (p=1.8e−5) cultureswith GPC6 also showing signiﬁcant upreg-
ulation (p = 0.02) in the astrocyte cultures when compared to basal
cultures (Fig. 5E). Finally, the HS Δ3G10 epitope was detected in basal
and lineage differentiated cultures via a Western analysis following
heparitinase digest with three major bands representing multiple
HSPGs associated with the cell membrane of approximately 70 kDa
(glypicans), 35 kDa and 15 kDa (syndecans) (Haupt et al., 2009). Rela-
tive quantitation normalised to GAPDH demonstrated higher intensity
for the 70 kDa band in neuronal and astrocyte cultures with the
35 kDa and 15 kDa bands demonstrating higher intensity in the basal
cultures suggesting HSPG modiﬁcations during lineage commitment.
SDC4, GPC1 and GPC4were further examined via IF under all culture
conditions demonstrating cellular localisation. Neuronal differentiating
cultures demonstrated strong SDC4 andGPC1 staining. Although the av-
erage signal intensity of these markers was not signiﬁcantly higher to
basal cells, GPC1 demonstrated signiﬁcantly stronger staining in neuro-
nal cells when compared to astrocyte cultures (p = 0.03). (Fig. 6A).
While IF of GPC4 did not demonstrate signiﬁcantly higher signal inten-
sity in the astrocyte cultures, high levels of expression were localised to
areas of dense cell-cell contact reﬂective of the observed phenotypic
changes when compared to the basal and neuronal cells (Fig. 6A). Final-
ly, to examine the potential inﬂuence of GPC1 and GPC4 on hNSC H9lineage potential, we downregulated the expression of these core pro-
teins in undifferentiated hNSC H9 P5 cells at the mRNA level using
gene speciﬁc RNAi pools and studied changes in marker genes in the
knockdown (KD) cultures compared to control conditions (untreated
and scramble). GPC1KD and GPC4KD cultures expressed signiﬁcantly
reduced levels of GPC1 (p = 1.6e−10, 58% reduction to control) and
GPC4 (p = 9.3e−8, 73% reduction to control), respectively, with no
changes observed in cell number or viability when compared to control
cultures (Fig. 6B). KD of GPC1 signiﬁcantly reduced the gene expression
levels of nestin (p= 0.005), MSI1 (p= 0.004), TUBB3 (p= 0.004) and
NEFM (p = 0.003) with the KD of GPC4 signiﬁcantly reducing NEFM
(p = 0.03) and S100B (p = 0.004) gene expression (Fig. 6C–D).
4. Discussion
Self-renewing and multipotent hNSCs provide an in vitro model to
study human neurogenesis and have potential in the regenerative treat-
ment of CNS injuries. Understanding themechanisms regulating expan-
sion, ‘stemness’ and lineage commitment of hNSCs is critical to our
improved understanding of the cells for these applications.With the ex-
tracellularmicroenvironment contributing to the regulation of stem cell
fate, cell-surface HSPGs associated with hNSCs and localised within the
neural niche may provide novel markers for the characterisation and
isolation of hNSCs and their progeny and with which to control hNSC
lineage speciﬁcation. The central ﬁndings of this study are summarised
in Fig. 7, with several HSPGs proposed as novel markers of hNSCs and
lineage speciﬁcity.
4.1. hNSC expansion, stemness, multi-lineage capacity and HSPGs
With limitations associated with the long-term culture of brain-
derived neurospheres (Anderson et al., 2007, Ostenfeld et al., 2000,
Wright et al., 2006, Zhang et al., 2001), we utilised adherent hESC-
derived NSCs (hNSC H9 cells) as a model of NSC self-renewal and
neurogenesis. During extended culture limited morphological changes
were observed in the cells with cultures continuing to express hTERT
aswell as increasedNSC self-renewal (SOX2) and neural lineagemarker
expression, (TUBB3, MAP2, S100B, Olig1 and Olig2) (Fig. 7) suggesting
that the cells maintain stemness and multipotency. Previous studies
utilising human neural progenitor cells (NPCs) isolated from the cortical
tissue have demonstrated the loss of neurogenic potential during ex-
tended culture as indicated by downregulation of neuronal markers,
such as TUBB3 and upregulation of glial markers, such as S100B
(Anderson et al., 2007, Wright et al., 2006). While glial markers were
also upregulated in hNSC H9 cells during long-term expansion, these
cells appear to also retain their self-renewal and neuronal
differentiative potential (SOX2, TUBB3 and MAP2) highlighting the ad-
vantage of utilising hESC-derived NSCs as a self-renewing NSC model.
HSPG ECM proteins including biosynthesis enzymes and cell-
anchored SDCs and GPCs regulate multiple cellular functions and are
potential targets for the control of hNSC fate. The expression of central
HS synthesising and modifying EXT1, NDST1 and HS2ST1 (Busse et al.,
2007, Grobe et al., 2002, Kreuger and Kjellen, 2012) in basal hNSC H9
cultures suggests active production of HS chains. The observed decrease
in expression of EXT1 and HS2ST1 during extended culture likely re-
ﬂects reduced synthesis of new HS chains with the increased 6-O-
sulfation suggesting continued modiﬁcation of the HS chains (Fig. 7).
HS chainmodiﬁcations are associatedwith a shift in growth factor bind-
ing abilities (e.g. FGF-2 vs. FGF-1) (Brickman et al., 1998, Johnson et al.,
2007), indicating altered requirements in hNSC H9 cells during
expansion.
Of the SDC andGPC core proteins, SDC1, SDC2, SDC3, GPC1 andGPC4
demonstrated high expression in basal hNSC H9 cells with extended
culture upregulating SDC2, SDC3, GPC2 and GPC4 expression (Fig. 7).
In addition, KD of GPC1 downregulated the expression of nestin in
basal hNSC H9 cells. Previous reports have shown SDC1, GPC1 and
Fig. 6. SDC4, GPC1 and GPC4 core proteins in hNSC H9 cell lineage speciﬁcation. A) Immunoﬂuorescence of SDC4, GPC1 and GPC4 in hNSC H9, neuronal and astrocyte lineage cells (20×
magniﬁcation, scale bar 130 μM)with representative average signal intensity (error bars= SD). B) Relative expression of GPC1 and GPC4 and cell number and viability in control hNSC H9
P5 cells and in GPC1andGPC4KDcultures. Relative expression of C) NSC andD)neural lineagemarkers followingGPC1 andGPC4KD (error bars=SEM, * p b 0.05, ** p b 0.01, *** p b 0.001).
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SDC3 have been shown to localise to rodent neurons and NSCs
(Abaskharoun et al., 2010, Fico et al., 2012, Ford-Perriss et al., 2003,
Hienola et al., 2006, Inatani et al., 2001, Wang et al., 2012) suggesting
these HSPGs are likely key contributors to the hNSC niche. Continued
dissection of the function of these HSPGs within the neural niche will
allow us to more fully understand their contribution to both stemness
and lineage speciﬁcation.4.2. Markers and HSPGs of neuronal differentiation of hNSCs
Understanding markers of neurogenesis is crucial for more efﬁcient
neuronal lineage differentiation of hNSCs. High expression levels of neu-
ronal markers in basal hNSC H9 cells indicated the high inherent neuro-
nal potential of these cells, conﬁrmed by upregulation of the neuronal
markers examined in neuronal lineage differentiative culture condi-
tions. Speciﬁc neuronal markers upregulated in neuronal lineage cells
Fig. 7.A schematic summary of changes inNSC and lineagemarkers (neuronal and glial), HS biosynthesis enzymes andHSPG core proteins inhNSCH9 cells. Key differenceswere identiﬁed
between early (P2–P5) and late (P27–P31) passage cultures and following neuronal and astrocyte lineage differentiation.
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TUBB3 (protein level), NEFM (transcript) and DCX (transcript)
(Fig. 7). Interestingly, MAP2 which is commonly used to characterise
neuronal lineage cells (Song et al., 2002), was highly upregulated in as-
trocyte cultures and showed no signiﬁcant difference in expression be-
tween neuronal and astrocyte cultures. This supports previous reports
of MAP2 functioning as a reactive astrocyte marker (Geisert et al.,
1990) indicating its lack of speciﬁcity to the neuronal lineage.
Neuronal differentiation of hNSC H9 cells induced the expression of
multiple HS biosynthesis enzymes, including EXT2, NDST2, NDST4,
HS6ST2 and HS6ST3 indicating altered HS biosynthesis activity follow-
ing neuronal commitment (Fig. 7). The upregulation of these enzymes
has been reported during embryoid body (EB) formation, the process
used as an intermediate step in the derivation of NSCs from ESCs
(Nairn et al., 2007). In addition, the upregulation of NDST4 and 6-O-
sulfotransferase gene expression has been shown to be highly upregu-
lated following neural differentiation of mouse ESCs indicating altered
HS sulfation and subsequent changes in growth factor binding (Grobe
et al., 2002, Johnson et al., 2007). With the increased expression of HS
modifying enzymes correlating with the upregulation of neuronal
markers, an importance for HS modiﬁcations during neuronal lineage
commitment is highlighted (Oikari et al., 2015).
Consistentwith increasedHS biosynthesis enzyme transcription, the
increased expression ofmultiple cell surfaceHSPG core proteins, includ-
ing SDC4, GPC1, GPC2, GPC3 and GPC6 were also observed following
neuronal differentiation (Fig. 7). Interestingly, SDC4 has previously
been identiﬁed as glial-speciﬁc (Avalos et al., 2009, Hsueh et al., 1998)
with its upregulation in neuronal cultures suggesting it may also have
a role in neuronal lineage speciﬁcation. The importance of, in particular,
GPC proteins in the neuronal lineage is supported by their coordinated
expression with neuronal lineage markers (Oikari et al., 2015) and pre-
vious studies reporting the localisation of GPC1 and GPC2 to rodentneurons (Ford-Perriss et al., 2003, Ivins et al., 1997, Jen et al., 2009,
Luxardi et al., 2007) as well as the reported upregulated expression of
GPC2, -3 and -6 following mouse EB differentiation (Nairn et al., 2007,
Zhang et al., 2001). Furthermore, in our study the downregulation of
GPC1 in basal hNSC H9 cells resulted in reduced expression of TUBB3
and NEFM, further highlighting the importance of GPCs in neuronal lin-
eage regulation.
4.3. Markers and HSPGs of astrocyte differentiation
The observed lowexpression levels of astrocyte and oligodendrocyte
markers in basal hNSC H9 cultures indicated low inherent glial
differentiative potential of the cells. The oligodendrocyte cultures of
hNSC H9 cells were not viable and the efﬁciency of astrocyte differenti-
ation was difﬁcult to determine, due to low expression levels of astro-
cyte lineage markers. However, the signiﬁcantly increased expression
of S100B following astrocyte differentiation compared to basal and neu-
ronal cultures indicated astrocyte lineage commitment of the cells
(Fig. 7). The NSCmarker MSI1, previously reportedly expressed in reac-
tive astrocytes (Oki et al., 2010) was also highly signiﬁcantly upregulat-
ed in astrocyte differentiation conditions, potentially providing a new
astrocyte speciﬁc marker (Fig. 7). With the glial marker CD44 showing
greater expression in the neuronal lineage cells, higher neuronal speci-
ﬁcity for this marker is indicated (Fig. 7) reinforcing the requirement to
deﬁne more accurate human astrocyte lineage markers.
Expression of the HS biosynthesis enzymes showed few changes fol-
lowing astrocyte differentiation likely reﬂective of the lower efﬁciency
of astrocyte differentiation. However, upregulation of NDST3 and
HS6ST1 following astrocyte commitment again suggests the importance
of HS modiﬁcations and the incorporation of 6-O-sulfation sites during
hNSC differentiation (Fig. 7). NDST3 has a more restricted expression
proﬁle than NDST1/2 but is expressed during embryonic development
103L.E. Oikari et al. / Stem Cell Research 16 (2016) 92–104(Nairn et al., 2007). Low levels of NDST3 were observed in basal hNSC
H9 cells and was upregulated following hNSC H9 (neuronal and astro-
cyte) lineage commitment suggesting NDST3 may play a role within
the neural niche during lineage speciﬁcation but not during stem cell
maintenance.
Our observed changes in the hNSC H9 HSPG proﬁle following astro-
cyte differentiation suggest GPC4 as an astrocyte lineagemarker (Fig. 7).
GPC4 expression at the gene expression levels was highly upregulated
in astrocyte cultures with its IF localisation demonstrating a distinct
“clustering” pattern that differed from basal and neuronal cultures.
Additionally, KD of GPC4 in basal hNSC H9 cultures resulted in the
downregulation of S100B further supporting its importance within as-
trocytes. Finally, the combination of GPC4 and GPC6 may be of impor-
tance in the astrocyte niche, as increased transcription of GPC6 was
also observed in the astrocyte cultures compared to basal cultures,
with previous studies in rodents further supporting this hypothesis
(Allen et al., 2012), Identiﬁcation of regulators of the astrocyte lineage
would greatly enhance the more efﬁcient derivation of astrocytes
from hNSCs.
5. Conclusions
Our data demonstrates hNSC H9 cells provide a goodmodel to study
human NSC self-renewal and neurogenesis and suggest HSPGs as im-
portant proteins of lineage speciﬁcity for these cells. The HSPG SDCs
were highly expressed in basal hNSC H9 cultures and lineage differenti-
ation resulted in an altered HSPG proﬁle with multiple GPC proteins
likely playing a role in neuronal differentiation and GPC4 identiﬁed as
a potential mediator of astrocyte differentiation. Overall, our results
support the importance of HS modiﬁcations during lineage commit-
ment and the requirement for continued reorganisation of the localised
niche during lineage speciﬁcation. Importantly, in combination with
identiﬁed lineage markers, HSPGs provide additional markers of hNSC
and neural cell lineage characterisation, and as cell surface proteins,
key HSPGs may provide targets to enable the more efﬁcient isolation,
enrichment and potentially differentiation of hNSCs and neural cell
lineages.
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